Found: 7
Select item for more details and to access through your institution.
Mixed-methods research to support the use of new lymphoma-specific patient-reported symptom measures derived from the EORTC item library.
- Published in:
- Journal of Patient-Reported Outcomes, 2024, v. 8, p. 1, doi. 10.1186/s41687-024-00683-2
- By:
- Publication type:
- Article
Outcomes for Patients With Chronic Lymphocytic Leukemia (CLL) Previously Treated With Both a Covalent BTK and BCL2 Inhibitor in the United States: A Real-World Database Study.
- Published in:
- 2023
- By:
- Publication type:
- journal article
Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: an analysis of the phase 3 REACH study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Cisplatin Induces Resistance by Triggering Differentiation of Testicular Embryonal Carcinoma Cells.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0087444
- By:
- Publication type:
- Article
Outcomes among Patients with Mantle Cell Lymphoma Post-Covalent BTK Inhibitor Therapy in the United States: A Real-World Electronic Medical Records Study.
- Published in:
- Advances in Hematology, 2022, p. 1, doi. 10.1155/2022/8262787
- By:
- Publication type:
- Article
Issue Cover.
- Published in:
- Liver International, 2019, v. 39, n. 12, p. i, doi. 10.1111/liv.14277
- By:
- Publication type:
- Article
Biology and significance of alpha‐fetoprotein in hepatocellular carcinoma.
- Published in:
- Liver International, 2019, v. 39, n. 12, p. 2214, doi. 10.1111/liv.14223
- By:
- Publication type:
- Article